These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21262116)

  • 21. Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.
    Sato M; Honzumi K; Sato T; Hashimoto K; Watanabe M; Miyazaki K; Kawasaki Y; Hosoya M
    J Clin Virol; 2015 Jul; 68():97-103. PubMed ID: 26071346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011-2012 influenza season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2014 Feb; 20(2):81-5. PubMed ID: 24486167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdomyolysis Following Initiation of Antiviral Therapy with Oseltamivir.
    Puttagunta H; Alghsoon S; Regula P; Hassankrishnamurthy S; Kota VK
    Am J Case Rep; 2018 Jun; 19():673-677. PubMed ID: 29887593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simply influenza A (H3N2)-associated encephalitis with seizure.
    Yuan HT; Ho TH; Lee JT; Chen PC; Wang CW; Yang FC
    Am J Emerg Med; 2019 Sep; 37(9):1808.e1-1808.e3. PubMed ID: 31230923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support.
    Geladari E; Papademetriou V; Moore H; Lu D
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):37-42. PubMed ID: 29113868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rhabdomyolysis and acute renal failure in human influenza A H1N1 mediated infection].
    Carrillo-Esper R; Ornelas-Arroyo S; Pérez-Bustos E; Sánchez-Zúñiga J; Uribe-Esquivel M
    Gac Med Mex; 2009; 145(6):519-21. PubMed ID: 20077871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First Documented Case of Influenza A (H3N2 Subtype) Infection in a Patient With Complete Interferon Gamma Receptor 1 Deficiency: A Call for Systemic Vaccination Strategies.
    Olbrich P; Falcón-Neyra L; Molinos-Quintana A; Aguero-Sánchez M; Neth O
    Pediatr Infect Dis J; 2016 Jun; 35(6):712-3. PubMed ID: 27171582
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aseptic meningitis in a child due to 2009 pandemic influenza A (H1N1) infection.
    Ozdemir H; Karbuz A; Ciftçi E; Ince E; Doğru U
    Turk J Pediatr; 2011; 53(1):91-3. PubMed ID: 21534347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.
    Cai J; Wang X; Zhao B; Yao W; Wang X; Zhu Q; Zeng M
    J Med Virol; 2014 Jun; 86(6):1026-33. PubMed ID: 24523140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
    Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient.
    Cohen-Daniel L; Zakay-Rones Z; Resnick IB; Shapira MY; Dorozhko M; Mador N; Greenbaum E; Wolf DG
    J Clin Virol; 2009 Feb; 44(2):138-40. PubMed ID: 19157971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A-associated rhabdomyolysis with acute renal failure.
    Dworschak AM; Wiebe B; Pohlmann U; Ehlen M; Scholer-Everts R; Bartmann P
    Klin Padiatr; 2008; 220(4):266-7. PubMed ID: 18654946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
    Haidari M; Ali M; Ward Casscells S; Madjid M
    Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute respiratory distress syndrome secondary to influenza A (H1N1) infection: a report of a case].
    Chouaib N; Bensghir M; Chouikh C; Chkoura K; Azendour H; Balkhi H; Haimeur C; Drissi Kamili N
    Rev Pneumol Clin; 2012 Jun; 68(3):209-12. PubMed ID: 22206788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.